Global Veterinary Therapeutics Market Status and Future Forecast 2015-2024
SKU ID :99ST-13117625 | Published Date: 19-Feb-2019 | No. of pages: 143Description
TOC
Table of Contents
Part 1 Market Overview
1.1 Market Definition
1.2 Market Development
1.3 ByDrugs
1.4 By Vaccines
1.5 By Application
1.6 By Region
Part 2 Global Market Status and Future Forecast
2.1 Global Market by Region
2.2 Global Market by Company
2.3 Global Market by Drugs
2.4 Global Market by Vaccines
2.5 Global Market by Application
2.6 Global Market by Forecast
Part 3 Asia-Pacific Market Status and Future Forecast
3.1 Asia-Pacific Market by Company
3.2 Asia-Pacific Market by Drugs
3.3 Asia-Pacific Market by Vaccines
3.4 Asia-Pacific Market by Application
3.5 Asia-Pacific Market by Forecast
Part 4 Asia-Pacific Market by Geography
4.1 China Market Status and Future Forecast
4.1.1 China Market by Drugs
4.1.2 China Market by Vaccines
4.1.3 China Market by Application
4.1.4 China Market by Forecast
4.2 Southeast Asia Market Status and Future Forecast
4.2.1 Southeast Asia Market by Drugs
4.2.2 Southeast Asia Market by Vaccines
4.2.3 Southeast Asia Market by Application
4.2.4 Southeast Asia Market by Forecast
4.3 India Market Status and Future Forecast
4.3.1 India Market by Drugs
4.3.2 India Market by Vaccines
4.3.3 India Market by Application
4.3.4 India Market by Forecast
4.4 Japan Market Status and Future Forecast
4.4.1 Japan Market by Drugs
4.4.2 Japan Market by Vaccines
4.4.3 Japan Market by Application
4.4.4 Japan Market by Forecast
4.5 Korea Market Status and Future Forecast
4.5.1 Korea Market by Drugs
4.5.2 Korea Market by Vaccines
4.5.3 Korea Market by Application
4.5.4 Korea Market by Forecast
4.6 Oceania Market Status and Future Forecast
4.6.1 Oceania Market by Drugs
4.6.2 Oceania Market by Vaccines
4.6.3 Oceania Market by Application
4.6.4 Oceania Market by Forecast
Part 5 Europe Market Status and Future Forecast
5.1 Europe Market by Region
5.2 Europe Market by Company
5.3 Europe Market by Drugs
5.4 Europe Market by Vaccines
5.5 Europe Market by Application
5.6 Europe Market by Forecast
Part 6 Europe Market by Geography
6.1 Germany Market Status and Future Forecast
6.1.1 Germany Market by Drugs
6.1.2 Germany Market by Vaccines
6.1.3 Germany Market by Application
6.1.4 Germany Market by Forecast
6.2 UK Market Status and Future Forecast
6.2.1 UK Market by Drugs
6.2.2 UK Market by Vaccines
6.2.3 UK Market by Application
6.2.4 UK Market by Forecast
6.3 France Market Status and Future Forecast
6.3.1 France Market by Drugs
6.3.2 France Market by Vaccines
6.3.3 France Market by Application
6.3.4 France Market by Forecast
6.4 Italy Market Status and Future Forecast
6.4.1 Italy Market by Drugs
6.4.2 Italy Market by Vaccines
6.4.3 Italy Market by Application
6.4.4 Italy Market by Forecast
6.5 Russia Market Status and Future Forecast
6.5.1 Russia Market by Drugs
6.5.2 Russia Market by Vaccines
6.5.3 Russia Market by Application
6.5.4 Russia Market by Forecast
6.6 Spain Market Status and Future Forecast
6.6.1 Spain Market by Drugs
6.6.2 Spain Market by Vaccines
6.6.3 Spain Market by Application
6.6.4 Spain Market by Forecast
6.7 Netherlands Market Status and Future Forecast
6.7.1 Netherlands Market by Drugs
6.7.2 Netherlands Market by Vaccines
6.7.3 Netherlands Market by Application
6.7.4 Netherlands Market by Forecast
6.8 Turkey Market Status and Future Forecast
6.8.1 Turkey Market by Drugs
6.8.2 Turkey Market by Vaccines
6.8.3 Turkey Market by Application
6.8.4 Turkey Market by Forecast
6.9 Switzerland Market Status and Future Forecast
6.9.1 Switzerland Market by Drugs
6.9.2 Switzerland Market by Vaccines
6.9.3 Switzerland Market by Application
6.9.4 Switzerland Market by Forecast
Part 7 North America Market Status and Future Forecast
7.1 North America Market by Region
7.2 North America Market by Company
7.3 North America Market by Drugs
7.4 North America Market by Vaccines
7.5 North America Market by Application
7.6 North America Market by Forecast
Part 8 North America Market by Geography
8.1 United States Market Status and Future Forecast
8.1.1 United States Market by Drugs
8.1.2 United States Market by Vaccines
8.1.3 United States Market by Application
8.1.4 United States Market by Forecast
8.2 Canada Market Status and Future Forecast
8.2.1 Canada Market by Drugs
8.2.2 Canada Market by Vaccines
8.2.3 Canada Market by Application
8.2.4 Canada Market by Forecast
8.3 Mexico Market Status and Future Forecast
8.3.1 Mexico Market by Drugs
8.3.2 Mexico Market by Vaccines
8.3.3 Mexico Market by Application
8.3.4 Mexico Market by Forecast
Part 9 South America Market Status and Future Forecast
9.1 South America Market by Region
9.2 South America Market by Company
9.3 South America Market by Drugs
9.4 South America Market by Vaccines
9.5 South America Market by Application
9.6 South America Market by Forecast
Part 10 South America Market by Geography
10.1 Brazil Market Status and Future Forecast
10.1.1 Brazil Market by Drugs
10.1.2 Brazil Market by Vaccines
10.1.3 Brazil Market by Application
10.1.4 Brazil Market by Forecast
10.2 Argentina Market Status and Future Forecast
10.2.1 Argentina Market by Drugs
10.2.2 Argentina Market by Vaccines
10.2.3 Argentina Market by Application
10.2.4 Argentina Market by Forecast
10.3 Columbia Market Status and Future Forecast
10.3.1 Columbia Market by Drugs
10.3.2 Columbia Market by Vaccines
10.3.3 Columbia Market by Application
10.3.4 Columbia Market by Forecast
10.4 Chile Market Status and Future Forecast
10.4.1 Chile Market by Drugs
10.4.2 Chile Market by Vaccines
10.4.3 Chile Market by Application
10.4.4 Chile Market by Forecast
10.5 Peru Market Status and Future Forecast
10.5.1 Peru Market by Drugs
10.5.2 Peru Market by Vaccines
10.5.3 Peru Market by Application
10.5.4 Peru Market by Forecast
Part 11 Middle East & Africa Market Status and Future Forecast
11.1 Middle East & Africa Market by Region
11.2 Middle East & Africa Market by Company
11.3 Middle East & Africa Market by Drugs
11.4 Middle East & Africa Market by Vaccines
11.5 Middle East & Africa Market by Application
11.6 Middle East & Africa Market by Forecast
Part 12 Middle East & Africa Market by Geography
12.1 GCC Market Status and Future Forecast
12.1.1 GCC Market by Drugs
12.1.2 GCC Market by Vaccines
12.1.3 GCC Market by Application
12.1.4 GCC Market by Forecast
12.2 North Africa Market Status and Future Forecast
12.2.1 North Africa Market by Drugs
12.2.2 North Africa Market by Vaccines
12.2.3 North Africa Market by Application
12.2.4 North Africa Market by Forecast
12.3 South Africa Market Status and Future Forecast
12.3.1 South Africa Market by Drugs
12.3.2 South Africa Market by Vaccines
12.3.3 South Africa Market by Application
12.3.4 South Africa Market by Forecast
Part 13 Key Companies
13.1 Bayer AG
13.2 Boehringer Ingelheim GmbH
13.3 Ceva Sante Animale
13.4 Dechra Pharmaceuticals PLC
13.5 Eli Lilly and Company (Elanco Animal Health)
13.6 Merck Animal Health
13.7 Sanofi (Merial Animal Health)
13.8 Virbac
13.9 Vetoquinol S.A.
13.10 Zoetis, Inc.
Part 14 Conclusion
Tables & Figures
Companies
- PRICE
-
$4500$9000